Jyothy Labs share price today

Jyothy Labs Ltd's share price was ₹188.13 at the close on 4 November 2026. It has been falling for 99 weeks. That is 15.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹172 and ₹312, and at that close it sat 12% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Jyothy Labs Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running.

Over the last 11 years the share price moved +31% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 14 quarters in a row (every quarter we can compare), lowest operating margin in 18 quarters and indian funds and insurers (DIIs) cut their stake for 4 quarters in a row.

1. Revenue up on a year earlier for 14 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹773 crore, +2.9% on a year earlier.

   Why: Revenue rose because Fabric Care grew strongly, with value up over 14% and volume up 10%.

   Next results: check whether revenue excluding Pril/Fa grows at the double-digit pace management expects.

   From the earnings call on 12 Aug 2026.

2. Lowest operating margin in 18 quarters

   Operating margin was 8% in the June 2026 quarter, against 17% a year earlier.

   Why: Margins fell because raw material and packing costs jumped, and price increases did not fully catch up.

   From the earnings call on 12 Aug 2026.

3. Indian funds and insurers (DIIs) cut their stake for 4 quarters in a row

   From 16.1% to 9.9% of the company by the September 2026 quarter.

For April to June 2026 (the quarter ended 30 June 2026), Jyothy Labs reported revenue of ₹773 crore, up 2.9% from ₹751 crore a year earlier, and a profit of ₹48.0 crore, down 50.5% from ₹97.0 crore.

Jyothy Labs results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Jyothy Labs' management discussed these results on a call held on 12 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Jyothy Labs closed at ₹188.13 on 4 November 2026, down 39.8% from ₹312.35 a year earlier (7 November 2025) and up 19.0% over five years. Its highest weekly close since March 2016 was ₹556.90 on 13 September 2024.

Jyothy Labs share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

562 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Jyothy Labs closed at ₹188.13, up 9.4% on the week and up 2.9% on the month. 12 Aug 2026: Jyothy Labs held its results call for April to June 2026. Management guided: FY27 revenue excluding Pril/Fa expected to grow double digit.

Earlier

• Results for April to June 2026: Revenue up 2.9% and profit down 50.5% on a year earlier.
• 29 Jun 2026: ex-date for a dividend of ₹3.50 a share.

Jyothy Labs paid ₹3.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.86% at the ₹188.13 close on 4 November 2026. The last was a dividend of ₹3.50 a share, ex-date 29 June 2026.

Jyothy Labs dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Jyothy Labs Ltd paid out 39% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 12 August 2026, Jyothy Labs' management guided: FY27 revenue excluding Pril/Fa expected to grow double digit.

“We will assess that at the relevant point in time, Ronak. Right now, we will see what we have to do, and more people are welcome to the party.”Jyothy, on the call for April to June 2026

What management guided

• July to September 2026 revenue excluding Pril/Fa planned at double digit; Personal Care expected to rejoin momentum from Q2; reported growth including Pril/Fa around 5%.
• FY27 high-single-digit volume growth expected throughout the year.
• Total pricing actions of about 4-4.5%, with 3% flowed through Q1 and the balance expected in Q2.
• FY27 operating margin likely to remain under pressure, with H2 substantially better than H1.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 12 August 2026.

When Jyothy Labs reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Ex-Pril/Fa Home Care growth, Exo liquid substitution and Maxo distribution - check whether early progress broadens across channels.

Jyothy Labs is on 2 of our India lists: 52 week high & low and Dividend stocks.

Jyothy Labs Ltd earned ₹48.0 Cr of net profit in the Jun 2026 quarter, −50.5% on the same quarter a year earlier. Full-year FY26 profit was ₹333 Cr. Over 10 years profit has grown 16.1% a year on average. That is 6.2% of the quarter's revenue. The same quarter a year earlier earned ₹97.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹333 Cr (−10.2% on the year before).

Why profit moved: revenue changed +2.9% on a year earlier and the margin moved −9.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −21.3% and revenue +4.0%. Profit is growing slower than sales: rising costs are taking part of the growth.

Jyothy Labs Ltd reported ₹773 Cr of revenue in the Jun 2026 quarter, +2.9% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 6.7% a year on average. The last full year, FY26, came in at ₹2,944 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹2,966 Cr.

FY26 revenue was ₹2,944 Cr, +3.5% on the year before.

Recent pace: the last four quarters grew +4.0% on average, against 6.7% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +3.9%, against +2.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −22.1%, against −12.8% a year (rolling over).

Jyothy Labs Ltd's operating margin was 8.0% in the Jun 2026 quarter, 9.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 11.0% and 18.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −8.2 percentage points on the year while gross margin changed −9.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 110% of Jyothy Labs Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹412 Cr of operating cash against ₹333 Cr of profit. After ₹93.0 Cr of spending on assets, ₹319 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 110% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Jyothy Labs Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 38 days in FY26, down from 48 days in FY21. It spent ₹231 Cr on assets over the last 3 years. Customers take 32 days to pay, and stock sits for 80 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹2,944 Cr, each day of that cycle ties up about ₹8.1 Cr, so roughly ₹306 Cr is tied up in the business at any time.

FY26: customers took 32 days to pay and stock sat for 80 days, about 2.6 months of sales sitting as stock, for a full cycle of 38 days, shorter than FY21's 48.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 80 days. Customers pay about 32 days after that. Suppliers are paid at 74 days. Together that makes the 38-day cycle.

Spending on assets: ₹231 Cr over the last 3 years, against ₹167 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹10.0 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Jyothy Labs Ltd's P/E is 24.3×, near the low end of its own history: it has been lower only 7% of the time. Its usual P/E (the middle reading) is 33.9×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.